secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001837607-25-000013
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.03, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AEON Biopharma approves 1-for-72 reverse stock split to maintain NYSE American listing
--------------------------------------------------------------------------------

- Reverse split ratio of 1-for-72; effective 12:01 AM ET on February 26, 2025.
- Outstanding shares reduced from ~79.9 million to ~1.1 million; fractional shares rounded up.
- Authorized shares increased from 500 million to 1.04 billion at special meeting.
- Ticker 'AEON' unchanged; new CUSIP 00791X 209; votes: 32.6M for, 3.6M against.
- Purpose: increase share price to comply with NYSE American continued listing standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000183760725000013/0001837607-25-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000183760725000013/aeon-20250224x8k.htm
  HTML page:      https://secwatch.observer/filing/0001837607-25-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer